CVE-2016-8358

8.5 HIGH
Published: February 13, 2017 Modified: May 13, 2026
View on NVD

Description

An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1. The affected software does not verify the identities at communication endpoints, which may allow a man-in-the-middle attacker to gain access to the communication channel between endpoints.

AI Explanation

Get an AI-powered plain-language explanation of this vulnerability and remediation steps.

Login to generate AI explanation

CVSS v3.x Details

0.0 Low Medium High Critical 10.0
Vector String
CVSS:3.0/AV:N/AC:H/PR:L/UI:N/S:C/C:H/I:H/A:H

References to Advisories, Solutions, and Tools

Patch Vendor Advisory Exploit Third Party Advisory
http://www.securityfocus.com/bid/94630
Source: ics-cert@hq.dhs.gov
Third Party Advisory VDB Entry
https://ics-cert.us-cert.gov/advisories/ICSMA-16-306-01
Source: ics-cert@hq.dhs.gov
Third Party Advisory US Government Resource
http://www.securityfocus.com/bid/94630
Source: af854a3a-2127-422b-91ae-364da2661108
Third Party Advisory VDB Entry
https://ics-cert.us-cert.gov/advisories/ICSMA-16-306-01
Source: af854a3a-2127-422b-91ae-364da2661108
Third Party Advisory US Government Resource

4 reference(s) from NVD

Quick Stats

CVSS v3 Score
8.5 / 10.0
EPSS (Exploit Probability)
0.5%
39th percentile
Exploitation Status
Not in CISA KEV

Weaknesses (CWE)

Affected Vendors

smiths-medical